The latest report by IMARC Group, titled “United States HIV Drugs Market Report by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors — CCR5 Co-Receptor Antagonist, Fusion Inhibitors, and Others), Distribution...